Search
Close this search box.
Search
Close this search box.
Search
Close this search box.

MENA

 The Top 5 Best Places to Work in UAE for 2023 Revealed

DUBAI, UAE – Media OutReach Newswire – 5 January 2024 – BSH, MoneyGram Novo Nordisk, Globalpharma and Middle East Specialized Cables are recognized as the top 5 best places to work in UAE for 2023 according to the annual prestigious “Best Places to Work” certification program. Best Places to Work is an international certification program, considered […]

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EGRX

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) between August 8, 2023 and November 28, 2023, both dates inclusive (the “Class Period”). A class action […]

CMI INVESTOR ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cummins Inc. Investors to Inquire About Securities Class Action Investigation – CMI

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cummins Inc. (NYSE: CMI) resulting from allegations that Cummins may have issued materially misleading business information to the investing public. SO WHAT: If you purchased […]

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline. SO WHAT: If you purchased ACELYRIN […]

Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline

Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from […]

Dr. N. Krishna Reddy appointed CEO and Dr. Sten Vermund inducted to ACCESS Health International’s Board of Directors

HYDERABAD, INDIA – Media OutReach Newswire – 4 January 2024 – ACCESS Health International, a globally recognized health systems think tank and advisory group, today announced two important leadership transitions. Dr. N. Krishna Reddy, who has been leading the operations as President across Asia, Middle East, and North Africa, has been appointed Chief Executive Officer. Concurrently, the organization […]

Enovis Completes Acquisition of LimaCorporate S.p.A

WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology growth company, today announced that it closed the acquisition of LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions. Lima strengthens Enovis’ position in the global orthopedic reconstruction […]